about
Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brainDifferential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.Pralidoxime and l-lactate effects in vitro on the inhibition of acetylcholinesterase by paraoxon: pralidoxime does not confer superior protection.The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytesThe endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.Cellular and molecular actions of Methylene Blue in the nervous systemMetabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS.Captopril as a potential inhibitor of lung tumor growth and metastasis.Methylene blue inhibits function of the 5-HT transporterAnalysis of pyridinium aldoximes - a chromatographic approach.Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy.Methylene blue and Alzheimer's disease.On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.Medicinal chemistry of drugs with active metabolites following conjugation.Distribution of neuroendocrine cells in the small and large intestines of the one-humped camel (Camelus dromedarius).Biologic activity of cyclic and caged phosphates: a review.Optimal Pre-treatment for Acute Exposure to the Organophosphate Dicrotophos.Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells.Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.Role of sialoglycan structures for the function of the epidermal growth factor receptor and the in vitro proliferation of head and neck cancer.In vitro assessment of the antibiotic efficacy of contrast media and antibiotics and their combinations at various dilutions.Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium.New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon.Study on medicinal chemistry of K203 in wistar rats and beagle dogs.Paraoxon sensitive phenylvalerate hydrolase in assessing the severity of acute paraoxon poisoning.High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs.Kinetics of intravenous L-lactic acid in anaesthetized minipigs under normoxic/normocapnic/normohydrogenaemic conditions.Influence of paraoxon (POX) and parathion (PAT) on apoptosis: a possible mechanism for toxicity in low-dose exposure.In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors.Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone.In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.Prehospital percutaneous venous cannulation: the "Unicorn" case.Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats.The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure.Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.Analysis of pralidoxime in serum, brain and CSF of rats.Hiccups and dopamine.
P50
Q28188520-8FC7093D-DB16-43A7-9CC1-807028927B71Q30478659-6A2C289B-E4B0-42D5-9954-C13BC1255D9CQ31948050-E7E64B30-BB9C-4BCA-A16B-E628B431D643Q33861917-2AE59C1D-277B-4F51-8206-5A513E0422BCQ34181090-E5052F69-377A-4E6A-B56B-18411AAABBB3Q34422385-D0D2CDE0-021F-4711-A6F9-FBBEBA921F7AQ34608054-78C7BCBF-34A3-4F4C-9D51-968692775784Q34846520-C3442751-C556-4BF8-95F7-4AE175DF3E94Q36153257-9E08F5CA-A9A5-4C54-9D02-9FA45457FE66Q37294273-0F1D9C87-5A0B-41CE-A12E-BF260BE15262Q37320572-916BC27F-0EFB-499D-8B6F-7F36E81A4DF3Q37477451-183B11A9-D5A0-4EBB-99BC-A9B1206CE9EEQ38102758-1692F5D8-BFC4-4DA6-BA92-8A46F6ADEA37Q38133808-574695D5-8FFA-40A8-AAB5-4FFF62C150BEQ38868940-ABB7DC96-5A54-4898-B1FB-FA09C620D767Q38950271-4F086813-099F-4B6E-96F4-FE4AD4124975Q39230283-80C4E669-ACBC-4CE5-8D29-2835D2FCA17AQ39632283-C2E38C48-F5F4-4B4C-B3C1-B1C893EC0988Q40082051-4A61267D-92BD-4E30-846A-33409C0AB986Q40997263-3D9F74B3-DCFF-4BBB-9E4C-B22CBA8387DEQ42420246-6725FFF4-4A0B-4533-B09B-B401B2F33303Q43090519-6769CBFF-C27E-4088-A7EC-D74BEC24DEB1Q43215825-C3BA23ED-458D-4C59-8F77-D4D8B1C6FDA4Q43493878-C54C4577-5C1D-4E9C-9CF8-94993EA689EBQ43591053-11B1DAEA-8C41-403D-86B7-284466699C65Q43693297-2F0082AF-0B9A-446E-88AC-1C95E2F5B275Q43825118-98D90B19-621A-4762-A2A2-AFC0D6D37AC5Q44272389-8763EA42-F97C-41BE-BB7F-50E89CAD8754Q44272407-7953F7EB-59FD-4CCA-ABA4-5B4E831298B2Q44289477-637C902B-A14A-4193-BF08-D0467BCBBDFAQ44685508-99EB667A-884E-47E8-AC4E-E5BE77DA64F6Q44732622-9C38FB28-28EF-4043-89C5-0A07008C273EQ44820917-07DC99A1-3E78-4720-AC87-819B7FD97607Q45209618-F9822478-9449-44E6-8447-ADB266EB2491Q45237218-65B3AE90-2B79-48CA-8055-6D130932F3F2Q45240305-9ECB8DD6-9739-4219-8805-F6ABBD41871FQ45895699-6C38AAB9-625E-4768-BD45-56EBA533B4E6Q45969401-ACA263D6-B9AE-4DCE-800B-DCF9D039A48BQ46012261-EF4AE6E0-8B55-4260-BD7A-DFBA7A1F17B8Q46255919-9FBDC3D0-3DEC-46F9-A8AC-D89E00861507
P50
description
researcher
@en
wetenschapper
@nl
name
Georg A Petroianu
@en
Petroianu GA
@nl
type
label
Georg A Petroianu
@en
Petroianu GA
@nl
altLabel
Petroianu GA
@en
prefLabel
Georg A Petroianu
@en
Petroianu GA
@nl
P106
P31
P496
0000-0001-9110-4750